BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 794415)

  • 1. Guinea pig lymphocyte-derived macrophage aggregation factor: its separation from macrophage migration inhibitory factor.
    Postlethwaite AE; Kang AH
    J Immunol; 1976 Nov; 117(5 Pt 1):1651-5. PubMed ID: 794415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of macrophage migration inhibitory factor activity produced in vivo by a cell-mediated immune reaction in the guinea pig.
    Postlethywaite AE; Townes AS; Kang AH
    J Immunol; 1976 Nov; 117(5 Pt 1):1716-20. PubMed ID: 794416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Charge-reducing lymphokine activity in Concanavalin A-stimulated lymphocyte supernatants: preliminary biological and biochemical characterization.
    Kotzsch M; Grossmann H; Irmscher J; Wagner H; Müller M
    Biomed Biochim Acta; 1984; 43(1):57-65. PubMed ID: 6372798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latent lymphokines: isolation of guinea pig latent lymphocyte-derived chemotactic factor for monocytes. Its activation by trypsin and a soluble factor from macrophages.
    Postlethwaite AE; Kang AH
    J Immunol; 1979 Aug; 123(2):561-7. PubMed ID: 458146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of lymphocyte mitogenic factor released in vivo during a cell-mediated immune reaction in the guinea pig.
    Postlethwaite AE
    J Immunol; 1980 Nov; 125(5):1955-8. PubMed ID: 6968767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial purification and physicochemical properties of human T cell migration inhibitory factor (TIF).
    Kowalczyk D; Staykowa M; Litwora E; Pryjma J; Zembala M
    J Clin Lab Immunol; 1984 Oct; 15(2):105-10. PubMed ID: 6394762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sensitive technique for measuring specific macrophage aggregation: a comparison with macrophage migration inhibition, for the detection of lymphokine activity.
    Rouveix B; Badenoch-Jones P; Turk JL
    Immunology; 1979 Mar; 36(3):589-94. PubMed ID: 374256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of leucocyte inhibitory factor (LIF) and macrophage inhibitory factor (MIF) by PHA-stimulated lymphocytes.
    Ruthlomnitzer ; Rabson AR; Koornhof HJ
    Clin Exp Immunol; 1975 Dec; 22(3):522-7. PubMed ID: 773578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage requirement for production of guinea pig migration inhibitory factor (MIF) in vitro.
    Nelson RD; Leu RW
    J Immunol; 1975 Feb; 114(2 Pt 1):606-9. PubMed ID: 47355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphokines. II. Use of horse monocytes as indicator cells for human MIF.
    Friedrich W; Lazary S; de Weck AL
    Int Arch Allergy Appl Immunol; 1976; 50(2):142-54. PubMed ID: 1107231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The production of anti-guinea pig lymphokine antibody.
    Yoshida T; Bigazzi PE; Cohen S
    J Immunol; 1975 Feb; 114(2 Pt 1):688-91. PubMed ID: 1091701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial purification and chemical characterization of macrophage cytotoxicity factor (MCF, MAF) and its separation from migration inhibitory factor (MIF).
    Kniep EM; Domzig W; Lohmann-Matthes ML; Kickhöfen B
    J Immunol; 1981 Aug; 127(2):417-22. PubMed ID: 6166671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histamine-induced suppressor factor (HSF): effect on migration inhibitory factor (MIF) production and proliferation.
    Rocklin RE
    J Immunol; 1977 May; 118(5):1734-8. PubMed ID: 67146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guinea pig macrophage agglutination factor is antigenically distinct from migration inhibition factor and immunoglobulin.
    Godfrey HP; Geczy CL
    J Immunol; 1978 Oct; 121(4):1428-31. PubMed ID: 359706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A lymphokine resembling transfer factor that stimulates MIF production by nonsensitive lymphocytes.
    Philp JR; McCormack JG; Moore AL; Johnson JE
    J Immunol; 1981 Apr; 126(4):1469-72. PubMed ID: 7009741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of macrophage Fc-dependent phagocytosis by resident thymocytes: effect of a unique heat-stable lymphokine.
    Coleman DL; Root RK; Ryan JL
    J Immunol; 1983 May; 130(5):2195-9. PubMed ID: 6339624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of human macrophage activation factor (MAF) prepared from antigen-stimulated lymphocytes.
    Cameron DJ
    J Clin Lab Immunol; 1984 Jan; 13(1):47-50. PubMed ID: 6371237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen-enhanced glucosamine incorporation by peritoneal macrophages in cell-mediated hypersensitivity. I. Studies on biology and mechanism.
    Hammond ME; Selvaggio SS; Dvorak HF
    J Immunol; 1975 Oct; 115(4):914-21. PubMed ID: 1100724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to guinea pig lymphokines. III. Reactions with radiolabeled lymphocyte activation products.
    Sorg C; Geczy CL
    Eur J Immunol; 1976 Oct; 6(10):688-93. PubMed ID: 797284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphokines in sensitized rats. I. Migration inhibitory factor(s) from specifically stimulated thymocytes in vitro.
    Bakker WW; Engelhart JJ; Mulder I; Hoedemaeker PJ
    Int Arch Allergy Appl Immunol; 1975; 49(4):491-503. PubMed ID: 1099009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.